Russia, Hualan Biological Bacterin agree on production of Sputnik V in China

Reuters, 19.04.2021

Russia's RDIF sovereign wealth fund said on Monday it had agreed with Hualan Biological Bacterin to produce more than 100 million doses of the Sputnik V vaccine against COVID-19 in China.

RDIF said the two sides were committed to a long-term partnership in vaccine production.